Protection against cisplatin-induced ototoxicity by N-acetylcysteine in a rat model

Research output: Contribution to journalArticle

95 Citations (Scopus)

Abstract

Cisplatin (CDDP) is a widely used chemotherapeutic agent that is highly ototoxic. Animal studies and clinical trials have shown that thiosulfates can protect against platinum-induced ototoxicity. This study investigated a new model for CDDP ototoxicity in the rat, and tested the potential chemoprotective effect of administering N-acetylcysteine (NAC) before giving CDDP. Long Evans rats were treated with CDDP 6 mg/kg delivered to the aorta via a retrograde right external carotid artery infusion, 15 min after intravenous (IV) infusion of saline (n=8) or NAC 400 mg/kg (n=8), such that the vertebral arteries were perfused. Subsequent groups were similarly treated with NAC 30 min before (n=7) and 4 h after (n=7) CDDP. Auditory brainstem response (ABR) thresholds were tested at 4-20 kHz, 7 days after treatment and compared to baseline ABR values. The NAC-treated rats exhibited no significant change from baseline values at all time intervals, while the saline-treated rats showed marked ototoxicity, especially at higher frequencies. Furthermore, the rats treated with NAC 15 min before CDDP exhibited less overall toxicity to CDDP, as evidenced in weight loss 7 days post-treatment (mean for saline=-39.63 g; mean for NAC=-21.13 g; p=0.0084). These data show that treatment with NAC can prevent CDDP-induced ototoxicity in rats.

Original languageEnglish (US)
Pages (from-to)25-30
Number of pages6
JournalHearing Research
Volume193
Issue number1-2
DOIs
StatePublished - Jul 2004

Fingerprint

Acetylcysteine
Cisplatin
Brain Stem Auditory Evoked Potentials
External Carotid Artery
Thiosulfates
Long Evans Rats
Vertebral Artery
Platinum
Intravenous Infusions
Aorta
Weight Loss
Therapeutics
Clinical Trials

Keywords

  • Animal model
  • Blood-brain barrier
  • Chemoprotection
  • Cisplatin
  • N-Acetylcysteine
  • Ototoxicity

ASJC Scopus subject areas

  • Sensory Systems

Cite this

Protection against cisplatin-induced ototoxicity by N-acetylcysteine in a rat model. / Dickey, D. Thomas; Muldoon, Leslie; Kraemer, Dale; Neuwelt, Edward.

In: Hearing Research, Vol. 193, No. 1-2, 07.2004, p. 25-30.

Research output: Contribution to journalArticle

@article{138651f5c3b644049027c5919b73b0ed,
title = "Protection against cisplatin-induced ototoxicity by N-acetylcysteine in a rat model",
abstract = "Cisplatin (CDDP) is a widely used chemotherapeutic agent that is highly ototoxic. Animal studies and clinical trials have shown that thiosulfates can protect against platinum-induced ototoxicity. This study investigated a new model for CDDP ototoxicity in the rat, and tested the potential chemoprotective effect of administering N-acetylcysteine (NAC) before giving CDDP. Long Evans rats were treated with CDDP 6 mg/kg delivered to the aorta via a retrograde right external carotid artery infusion, 15 min after intravenous (IV) infusion of saline (n=8) or NAC 400 mg/kg (n=8), such that the vertebral arteries were perfused. Subsequent groups were similarly treated with NAC 30 min before (n=7) and 4 h after (n=7) CDDP. Auditory brainstem response (ABR) thresholds were tested at 4-20 kHz, 7 days after treatment and compared to baseline ABR values. The NAC-treated rats exhibited no significant change from baseline values at all time intervals, while the saline-treated rats showed marked ototoxicity, especially at higher frequencies. Furthermore, the rats treated with NAC 15 min before CDDP exhibited less overall toxicity to CDDP, as evidenced in weight loss 7 days post-treatment (mean for saline=-39.63 g; mean for NAC=-21.13 g; p=0.0084). These data show that treatment with NAC can prevent CDDP-induced ototoxicity in rats.",
keywords = "Animal model, Blood-brain barrier, Chemoprotection, Cisplatin, N-Acetylcysteine, Ototoxicity",
author = "Dickey, {D. Thomas} and Leslie Muldoon and Dale Kraemer and Edward Neuwelt",
year = "2004",
month = "7",
doi = "10.1016/j.heares.2004.02.007",
language = "English (US)",
volume = "193",
pages = "25--30",
journal = "Hearing Research",
issn = "0378-5955",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Protection against cisplatin-induced ototoxicity by N-acetylcysteine in a rat model

AU - Dickey, D. Thomas

AU - Muldoon, Leslie

AU - Kraemer, Dale

AU - Neuwelt, Edward

PY - 2004/7

Y1 - 2004/7

N2 - Cisplatin (CDDP) is a widely used chemotherapeutic agent that is highly ototoxic. Animal studies and clinical trials have shown that thiosulfates can protect against platinum-induced ototoxicity. This study investigated a new model for CDDP ototoxicity in the rat, and tested the potential chemoprotective effect of administering N-acetylcysteine (NAC) before giving CDDP. Long Evans rats were treated with CDDP 6 mg/kg delivered to the aorta via a retrograde right external carotid artery infusion, 15 min after intravenous (IV) infusion of saline (n=8) or NAC 400 mg/kg (n=8), such that the vertebral arteries were perfused. Subsequent groups were similarly treated with NAC 30 min before (n=7) and 4 h after (n=7) CDDP. Auditory brainstem response (ABR) thresholds were tested at 4-20 kHz, 7 days after treatment and compared to baseline ABR values. The NAC-treated rats exhibited no significant change from baseline values at all time intervals, while the saline-treated rats showed marked ototoxicity, especially at higher frequencies. Furthermore, the rats treated with NAC 15 min before CDDP exhibited less overall toxicity to CDDP, as evidenced in weight loss 7 days post-treatment (mean for saline=-39.63 g; mean for NAC=-21.13 g; p=0.0084). These data show that treatment with NAC can prevent CDDP-induced ototoxicity in rats.

AB - Cisplatin (CDDP) is a widely used chemotherapeutic agent that is highly ototoxic. Animal studies and clinical trials have shown that thiosulfates can protect against platinum-induced ototoxicity. This study investigated a new model for CDDP ototoxicity in the rat, and tested the potential chemoprotective effect of administering N-acetylcysteine (NAC) before giving CDDP. Long Evans rats were treated with CDDP 6 mg/kg delivered to the aorta via a retrograde right external carotid artery infusion, 15 min after intravenous (IV) infusion of saline (n=8) or NAC 400 mg/kg (n=8), such that the vertebral arteries were perfused. Subsequent groups were similarly treated with NAC 30 min before (n=7) and 4 h after (n=7) CDDP. Auditory brainstem response (ABR) thresholds were tested at 4-20 kHz, 7 days after treatment and compared to baseline ABR values. The NAC-treated rats exhibited no significant change from baseline values at all time intervals, while the saline-treated rats showed marked ototoxicity, especially at higher frequencies. Furthermore, the rats treated with NAC 15 min before CDDP exhibited less overall toxicity to CDDP, as evidenced in weight loss 7 days post-treatment (mean for saline=-39.63 g; mean for NAC=-21.13 g; p=0.0084). These data show that treatment with NAC can prevent CDDP-induced ototoxicity in rats.

KW - Animal model

KW - Blood-brain barrier

KW - Chemoprotection

KW - Cisplatin

KW - N-Acetylcysteine

KW - Ototoxicity

UR - http://www.scopus.com/inward/record.url?scp=2142788844&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2142788844&partnerID=8YFLogxK

U2 - 10.1016/j.heares.2004.02.007

DO - 10.1016/j.heares.2004.02.007

M3 - Article

C2 - 15219317

AN - SCOPUS:2142788844

VL - 193

SP - 25

EP - 30

JO - Hearing Research

JF - Hearing Research

SN - 0378-5955

IS - 1-2

ER -